Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?

Hsin-Hua Chen,1–6 Der-Yuan Chen,1–3,6–8 Yi-Ming Chen,1–3 Chao-Hsiun Tang9 1Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China; 2School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China; 3Divisio...

Descripción completa

Detalles Bibliográficos

Autores principales:	Chen HH, Chen DY, Chen YM, Tang CH
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Dove Medical Press 2016-02-01
Colección:	Patient Preference and Adherence
Materias:	adalimumab etanercept methotrexate rheumatoid arthritis treatment discontinuation
Acceso en línea:	https://www.dovepress.com/is-drug-discontinuation-risk-of-adalimumab-compared-with-etanercept-af-peer-reviewed-article-PPA
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!